ATE322492T1 - Nicht-nukleosid reverse transkriptase inhibitoren - Google Patents

Nicht-nukleosid reverse transkriptase inhibitoren

Info

Publication number: ATE322492T1
Authority: AT; Austria
Prior art keywords: reverse transcriptase; transcriptase inhibitors; nucleoside reverse; nucleoside; inhibitors
Prior art date: 2000-06-16

Application number

AT01949124T

Other languages

English (en)

Inventor

Bruno Simoneau

Original Assignee

Boehringer Ingelheim Ca Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-16

Filing date

2001-06-14

Publication date

2006-04-15

2001-06-14 Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd

2006-04-15 Application granted granted Critical

2006-04-15 Publication of ATE322492T1 publication Critical patent/ATE322492T1/de

Links

229940042402 non-nucleoside reverse transcriptase inhibitor Drugs 0.000 title 1
239000002726 nonnucleoside reverse transcriptase inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
AIDS & HIV (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Saccharide Compounds (AREA)
Steroid Compounds (AREA)

AT01949124T 2000-06-16 2001-06-14 Nicht-nukleosid reverse transkriptase inhibitoren ATE322492T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US21232900P	2000-06-16	2000-06-16
US25663800P	2000-12-18	2000-12-18

Publications (1)

Publication Number	Publication Date
ATE322492T1 true ATE322492T1 (de)	2006-04-15

Family

ID=26907019

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01949124T ATE322492T1 (de)	2000-06-16	2001-06-14	Nicht-nukleosid reverse transkriptase inhibitoren

Country Status (35)

Country	Link
US (1)	US6420359B1 (de)
EP (1)	EP1294720B1 (de)
JP (1)	JP3923894B2 (de)
KR (1)	KR20030017540A (de)
CN (1)	CN1178939C (de)
AR (1)	AR028958A1 (de)
AT (1)	ATE322492T1 (de)
AU (2)	AU7037001A (de)
BG (1)	BG107348A (de)
BR (1)	BR0102377A (de)
CA (1)	CA2411766C (de)
CZ (1)	CZ20024114A3 (de)
DE (1)	DE60118560T2 (de)
DK (1)	DK1294720T3 (de)
EA (1)	EA005598B1 (de)
EE (1)	EE200200690A (de)
ES (1)	ES2261433T3 (de)
HR (1)	HRP20021003A2 (de)
HU (1)	HUP0301105A2 (de)
IL (1)	IL152819A0 (de)
MX (1)	MXPA02012205A (de)
MY (1)	MY130375A (de)
NO (1)	NO323830B1 (de)
NZ (1)	NZ523549A (de)
PE (1)	PE20020083A1 (de)
PL (1)	PL360370A1 (de)
PT (1)	PT1294720E (de)
SA (1)	SA01220202B1 (de)
SK (1)	SK17722002A3 (de)
TW (1)	TWI270547B (de)
UA (1)	UA74834C2 (de)
UY (1)	UY26767A1 (de)
WO (1)	WO2001096338A1 (de)
YU (1)	YU94202A (de)
ZA (1)	ZA200209807B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6716836B2 (en)	2001-03-22	2004-04-06	Boehringer Ingelheim (Canada) Ltd.	Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en) *	2001-07-30	2004-01-06	Boehringer Ingelheim (Canada) Ltd.	Non-nucleoside reverse transcriptase inhibitors
US6706706B2 (en) *	2002-03-27	2004-03-16	Boehringer Ingelheim International Gmbh	Non-nucleoside reverse transcriptase inhibitors
US6806265B2 (en) *	2002-05-16	2004-10-19	Boehringer Ingelheim International Gmbh	Non-nucleoside reverse transcriptase inhibitors
US6759533B2 (en) *	2002-06-28	2004-07-06	Boehringer Ingelheim Pharmaceuticals, Inc.	Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors
US7642277B2 (en)	2002-12-04	2010-01-05	Boehringer Ingelheim International Gmbh	Non-nucleoside reverse transcriptase inhibitors
KR20050085681A (ko) *	2002-12-16	2005-08-29	베링거 인겔하임 인터내셔날 게엠베하	프로테아제 억제제와 같은 사이토크롬 ｐ450의 억제제와함께 비-뉴클레오시드 역전사효소 억제제(ｎｎｒｔｉ)를함유하는 배합물의 용도
EP1610782A1 (de) *	2003-03-27	2006-01-04	Boehringer Ingelheim International GmbH	Antivirale kombination eines dipyridodiazepinons und einer weiteren antiretroviralen verbindung
US7309700B2 (en) *	2004-04-02	2007-12-18	Boehringer Ingelheim International Gmbh	Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2′,3′-e] [1,4]diazepin-6-one
US20060025480A1 (en)	2004-08-02	2006-02-02	Boehringer Ingelheim International Gmbh	Benzoic acid derivatives as non nucleoside reverse transcriptase inhibitors
US7151174B2 (en)	2004-11-05	2006-12-19	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Process for making a non-nucleoside HIV-1 reverse transcriptase inhibitor
WO2007067844A1 (en) *	2005-12-05	2007-06-14	Boehringer Ingelheim International Gmbh	Process for making 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-di pyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
EP2085390A1 (de) *	2008-01-31	2009-08-05	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Markierte Analoge von Halobenzamiden als multimodale Radiopharmazeutika und ihre Vorläufer
CA2758149A1 (en) *	2009-04-09	2010-10-14	Boehringer Ingelheim International Gmbh	Inhibitors of hiv replication

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5366972A (en) *	1989-04-20	1994-11-22	Boehringer Ingelheim Pharmaceuticals, Inc.	5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5705499A (en) *	1995-10-06	1998-01-06	Boehringer Ingelheim Pharmaceuticals, Inc.	8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection

2001
- 2001-05-30 TW TW090113049A patent/TWI270547B/zh not_active IP Right Cessation
- 2001-06-12 US US09/879,447 patent/US6420359B1/en not_active Expired - Lifetime
- 2001-06-12 BR BR0102377-2A patent/BR0102377A/pt not_active IP Right Cessation
- 2001-06-13 UY UY26767A patent/UY26767A1/es not_active Application Discontinuation
- 2001-06-14 DE DE60118560T patent/DE60118560T2/de not_active Expired - Lifetime
- 2001-06-14 EA EA200201255A patent/EA005598B1/ru not_active IP Right Cessation
- 2001-06-14 WO PCT/CA2001/000890 patent/WO2001096338A1/en not_active Ceased
- 2001-06-14 KR KR1020027017173A patent/KR20030017540A/ko not_active Abandoned
- 2001-06-14 JP JP2002510480A patent/JP3923894B2/ja not_active Expired - Lifetime
- 2001-06-14 AT AT01949124T patent/ATE322492T1/de active
- 2001-06-14 AU AU7037001A patent/AU7037001A/xx active Pending
- 2001-06-14 PE PE2001000560A patent/PE20020083A1/es not_active Application Discontinuation
- 2001-06-14 SK SK1772-2002A patent/SK17722002A3/sk not_active Application Discontinuation
- 2001-06-14 MX MXPA02012205A patent/MXPA02012205A/es active IP Right Grant
- 2001-06-14 EP EP01949124A patent/EP1294720B1/de not_active Expired - Lifetime
- 2001-06-14 CA CA002411766A patent/CA2411766C/en not_active Expired - Fee Related
- 2001-06-14 CZ CZ20024114A patent/CZ20024114A3/cs unknown
- 2001-06-14 DK DK01949124T patent/DK1294720T3/da active
- 2001-06-14 PT PT01949124T patent/PT1294720E/pt unknown
- 2001-06-14 EE EEP200200690A patent/EE200200690A/xx unknown
- 2001-06-14 HR HR20021003A patent/HRP20021003A2/hr not_active Application Discontinuation
- 2001-06-14 YU YU94202A patent/YU94202A/sh unknown
- 2001-06-14 HU HU0301105A patent/HUP0301105A2/hu unknown
- 2001-06-14 IL IL15281901A patent/IL152819A0/xx unknown
- 2001-06-14 ES ES01949124T patent/ES2261433T3/es not_active Expired - Lifetime
- 2001-06-14 AU AU2001270370A patent/AU2001270370B2/en not_active Ceased
- 2001-06-14 CN CNB018112692A patent/CN1178939C/zh not_active Expired - Fee Related
- 2001-06-14 PL PL36037001A patent/PL360370A1/xx not_active Application Discontinuation
- 2001-06-14 NZ NZ523549A patent/NZ523549A/en unknown
- 2001-06-14 UA UA2003010387A patent/UA74834C2/uk unknown
- 2001-06-15 AR ARP010102870A patent/AR028958A1/es unknown
- 2001-06-15 MY MYPI20012820A patent/MY130375A/en unknown
- 2001-07-07 SA SA01220202A patent/SA01220202B1/ar unknown
2002
- 2002-12-03 BG BG107348A patent/BG107348A/bg unknown
- 2002-12-03 ZA ZA200209807A patent/ZA200209807B/en unknown
- 2002-12-05 NO NO20025844A patent/NO323830B1/no unknown

Also Published As

Publication number	Publication date
CA2411766A1 (en)	2001-12-20
CN1178939C (zh)	2004-12-08
DE60118560T2 (de)	2006-09-28
DE60118560D1 (de)	2006-05-18
CN1436189A (zh)	2003-08-13
MXPA02012205A (es)	2003-09-10
UY26767A1 (es)	2002-01-31
CZ20024114A3 (cs)	2003-04-16
EP1294720B1 (de)	2006-04-05
HUP0301105A2 (hu)	2003-08-28
US6420359B1 (en)	2002-07-16
YU94202A (sh)	2005-11-28
BR0102377A (pt)	2002-02-19
AU7037001A (en)	2001-12-24
SK17722002A3 (sk)	2003-06-03
UA74834C2 (en)	2006-02-15
EP1294720A1 (de)	2003-03-26
SA01220202B1 (ar)	2006-09-05
WO2001096338A1 (en)	2001-12-20
AU2001270370B2 (en)	2006-08-03
TWI270547B (en)	2007-01-11
NO20025844D0 (no)	2002-12-05
DK1294720T3 (da)	2006-07-31
EA200201255A1 (ru)	2003-06-26
PL360370A1 (en)	2004-09-06
ZA200209807B (en)	2003-10-16
AR028958A1 (es)	2003-05-28
JP2004502787A (ja)	2004-01-29
JP3923894B2 (ja)	2007-06-06
BG107348A (bg)	2004-06-30
NO20025844L (no)	2002-12-05
IL152819A0 (en)	2003-06-24
NO323830B1 (no)	2007-07-09
KR20030017540A (ko)	2003-03-03
US20020028807A1 (en)	2002-03-07
NZ523549A (en)	2004-08-27
ES2261433T3 (es)	2006-11-16
CA2411766C (en)	2006-05-23
HRP20021003A2 (en)	2005-02-28
EA005598B1 (ru)	2005-04-28
MY130375A (en)	2007-06-29
PT1294720E (pt)	2006-06-30
PE20020083A1 (es)	2002-02-28
EE200200690A (et)	2004-06-15
HK1057558A1 (en)	2004-04-08

Legal Events

Date

Code

Title

Description

2007-02-15

UEP

Publication of translation of european patent specification

Ref document number: 1294720

Country of ref document: EP

Publication	Publication Date	Title
DE60117597D1 (de)	2006-04-27	Aufweitvorrichtung
ATE433451T1 (de)	2009-06-15	Xanthin-phosphodiesteras-v-inhibitoren
AR028253A1 (es)	2003-04-30	Inhibidores de la glucogeno fosforilasa
IS6668A (is)	2003-01-03	Kolkínólafleiður sem æðamyndunarhemlar
NO20032994L (no)	2003-08-27	VLA-4 inhibitorer
PL378556A1 (pl)	2006-05-02	Nienukleozydowe inhibitory odwrotnej transkryptazy
NO20024997D0 (no)	2002-10-17	2-guanidino-4-arylkinazoliner som NHE-3-inhibitorer
IL144349A0 (en)	2002-05-23	Non-nucleoside reverse transcriptase inhibitors
DK1272488T3 (da)	2006-07-17	Tri-aryl-substitueret ethan-PDE4-inhibitorer
NO20044104L (no)	2004-12-01	Ikke-nukleoside reverstranskriptase-inhibitorer
ATE322492T1 (de)	2006-04-15	Nicht-nukleosid reverse transkriptase inhibitoren
DE60139831D1 (de)	2009-10-22	Sicherung
ATE276445T1 (de)	2004-10-15	Spreizdübel
PT1339695E (pt)	2006-08-31	Inibidores da farnesiltransferase
DE60133976D1 (de)	2008-06-26	Turbomaschinen
ATE351991T1 (de)	2007-02-15	Spreizdübel
IL157543A0 (en)	2004-03-28	Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
EP1463521A4 (de)	2009-06-24	Gp41-hemmer
DK1130214T3 (da)	2005-08-29	Korrosionsinhibitorer
AR028075A1 (es)	2003-04-23	Inhibidores de la peptido-desformilasa
ATE331898T1 (de)	2006-07-15	Spreizdübel
EP1326640A4 (de)	2004-12-15	Nichtnucleosidischer reverse-transcriptase-hemmer als antiretrovirale therapie
DE60137845D1 (de)	2009-04-16	Rauscharmes spektroskopisches ellipsometer
DE60142585D1 (de)	2010-08-26	Fischer-tropsch-verfahren
DK1373267T3 (da)	2005-03-29	Non-nucleoside revers transkriptase-inhibitorer